Tetraphase Pharmaceuticals, Inc.
TTPH
TTPH was delisted on the 28th of July, 2020.
105 hedge funds and large institutions have $212M invested in Tetraphase Pharmaceuticals, Inc. in 2015 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 46 increasing their positions, 29 reducing their positions, and 52 closing their positions.
59% more repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 29
21% less call options, than puts
Call options by funds: $4.75M | Put options by funds: $6.01M
24% less funds holding
Funds holding: 139 → 105 (-34)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
63% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 52
84% less capital invested
Capital invested by funds: $1.3B → $212M (-$1.09B)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$84.5M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$82.4M |
| 3 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$41.1M |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$27.9M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$21.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
-$53.3M |
| 2 |
AllianceBernstein
Nashville,
Tennessee
|
-$36.9M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$35.2M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$29.7M |
| 5 |
PC
Polar Capital
London,
United Kingdom
|
-$22.9M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
MFS
151
MSI Financial Services
Springfield,
Massachusetts
| – | -$24K | -25 | Closed |
|
152
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | -$24K | -25 | Closed |
|
|
CIM
153
Cambria Investment Management
Manhattan Beach,
California
| – | -$12K | -13 | Closed |
|
|
MTIP
154
Magee Thomson Investment Partners
San Diego,
California
| – | -$5K | -6 | Closed |
|
|
ASN
155
Advisory Services Network
Atlanta,
Georgia
| – | -$1K | -2 | Closed |
|
TTPH Hedge Fund Activity: Q3 2015 in Review
105 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Tetraphase Pharmaceuticals, Inc. (TTPH) for Q3 2015, worth a combined $212M — down 84% from $1.3B a quarter earlier.
Sellers outnumbered buyers: 52 funds closed out of TTPH and 19 opened new positions — a net loss of 33 holders — while 29 trimmed existing stakes and 46 added.
The largest buyer was State Street, adding an estimated $84.5M. The largest seller was Jennison Associates, exiting entirely with an estimated $53.3M sold.
- 105 institutional investors held Tetraphase Pharmaceuticals, Inc. (TTPH) as of Q3 2015, down from 139 in Q2 2015.
- Funds reported $212M of Tetraphase Pharmaceuticals, Inc. stock for Q3 2015, down 84% quarter-over-quarter.
- 19 funds opened new Tetraphase Pharmaceuticals, Inc. positions in Q3 2015 and 52 closed out, a net change of -33 holders.
- The largest Tetraphase Pharmaceuticals, Inc. buyer in Q3 2015 was State Street, an estimated $84.5M added.
- The largest Tetraphase Pharmaceuticals, Inc. seller in Q3 2015 was Jennison Associates, an estimated $53.3M sold.
Based on aggregated 13F filings for Q3 2015.